2004
DOI: 10.1016/j.jpeds.2004.02.033
|View full text |Cite
|
Sign up to set email alerts
|

Brain damage in glycogen storage disease type I

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 39 publications
(21 citation statements)
references
References 11 publications
(2 reference statements)
1
19
0
1
Order By: Relevance
“…This is a common finding in many metabolic diseases that are characterized in general by complex phenotypes, involving several organs and systems, such as the central nervous system [6,7], the respiratory tract [8-11], the gastro-intestinal tract and liver [12-14], the muscolo-skeletal system [15-18], and the immune system. Such a wide variability and involvement of different systems may be confusing in the diagnostic approach to patients with metabolic disorders.…”
Section: Discussionmentioning
confidence: 99%
“…This is a common finding in many metabolic diseases that are characterized in general by complex phenotypes, involving several organs and systems, such as the central nervous system [6,7], the respiratory tract [8-11], the gastro-intestinal tract and liver [12-14], the muscolo-skeletal system [15-18], and the immune system. Such a wide variability and involvement of different systems may be confusing in the diagnostic approach to patients with metabolic disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed H6PDH is integrated in the pentose phosphate pathway to generate reducing equivalents in the form of NADPH, crucial for reductive biosynthesis within cells and necessary for provision of ribose-5-phosphate for synthesis of nucleotides and nucleic acids. However, the brain is not a prominent target in glycogen storage disease type 1 with damage correlating merely with hypoglycaemia, the major peripheral manifestation [170]. Clearly there is much to discover about the determinants driving 11β-reductase in brain cells.…”
Section: Reaction Direction Redox Potential and Hexose-6-phosphate Dmentioning
confidence: 99%
“…The incidence of BAEP changes correlated with the frequency of hypoglycemia episodes. 10 Exogenous potentials (SEP, VEP, BAEP) of our patients performed at the age of 4 years remain normal, which gives hope for the proper functioning of sensory organs in patients who are metabolically monitored and who undergo strict dietary and pharmacological treatment.…”
Section: Discussionmentioning
confidence: 77%